Zoetis, Inc. (ZTS)
83.82
+0.86
(+1.04%)
USD |
NYSE |
Nov 13, 16:00
83.82
0.00 (0.00%)
After-Hours: 17:25
Zoetis Price to Book Value : 10.34 for Nov. 13, 2026
Price to Book Value Chart
Historical Price to Book Value Data
| Date | Value |
|---|---|
| November 12, 2026 | 10.23 |
| November 11, 2026 | 10.19 |
| November 10, 2026 | 10.17 |
| November 09, 2026 | 10.16 |
| November 06, 2026 | 9.796 |
| November 05, 2026 | 10.13 |
| November 04, 2026 | 11.00 |
| November 03, 2026 | 10.24 |
| November 02, 2026 | 10.26 |
| October 30, 2026 | 9.835 |
| October 29, 2026 | 9.722 |
| October 28, 2026 | 9.598 |
| October 27, 2026 | 9.651 |
| October 26, 2026 | 9.989 |
| October 23, 2026 | 9.997 |
| October 22, 2026 | 10.12 |
| October 21, 2026 | 9.823 |
| October 20, 2026 | 9.874 |
| October 19, 2026 | 9.819 |
| October 16, 2026 | 9.793 |
| October 15, 2026 | 9.675 |
| October 14, 2026 | 9.288 |
| October 13, 2026 | 9.166 |
| October 12, 2026 | 9.333 |
| October 09, 2026 | 9.229 |
| Date | Value |
|---|---|
| October 08, 2026 | 9.016 |
| October 07, 2026 | 8.827 |
| October 06, 2026 | 8.800 |
| October 05, 2026 | 8.810 |
| October 02, 2026 | 8.598 |
| October 01, 2026 | 8.525 |
| September 30, 2026 | 8.615 |
| September 29, 2026 | 9.249 |
| September 28, 2026 | 9.397 |
| September 25, 2026 | 9.347 |
| September 24, 2026 | 9.245 |
| September 23, 2026 | 9.421 |
| September 22, 2026 | 9.586 |
| September 21, 2026 | 9.384 |
| September 18, 2026 | 9.394 |
| September 17, 2026 | 9.607 |
| September 16, 2026 | 9.604 |
| September 15, 2026 | 9.660 |
| September 14, 2026 | 9.692 |
| September 11, 2026 | 9.60 |
| September 10, 2026 | 9.586 |
| September 09, 2026 | 9.645 |
| September 08, 2026 | 9.678 |
| September 04, 2026 | 9.974 |
| September 03, 2026 | 10.04 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price to Book Value Benchmarks
| Merck & Co., Inc. | 8.118 |
| Phibro Animal Health Corp. | 3.498 |
| Eli Lilly & Co. | 33.76 |
| Pfizer Inc. | 1.851 |
| Bristol Myers Squibb Co. | 5.540 |
Price to Book Value Related Metrics
| PE Ratio | 14.24 |
| PS Ratio | 3.725 |
| Price to Free Cash Flow | 15.55 |
| Price | 83.82 |
| Earnings Yield | 7.02% |
| Market Cap | 34.16B |
| Operating PE Ratio | 9.969 |
| Normalized PE Ratio | 13.36 |